文献速递重症综合管理与镇静镇痛

SOFA-2评分在不同人口学亚组中的表现评估:基于MIMIC-IV的外部验证

Evaluation of Sequential Organ Failure Assessment-2 Performance Across Demographic Subgroups: An External Validation Using MIMIC-IV.
PubMed 文献 · Crit Care Med · 2026-11-11
一句话结论SOFA-2在ICU总体表现良好(AUROC 0.77),但年龄≥75岁者区分度显著下降(0.72 vs 18-44岁0.85),且系统性地低估老年患者死亡风险。

本研究为回顾性队列研究,利用美国东北部单中心MIMIC-IV数据库(2008-2022年)外部验证SOFA-2评分对ICU死亡率的区分度和校准度,覆盖年龄、性别、种族/民族、主要语言和保险状态等人口学亚组。共纳入64,015例成人ICU患者,总体AUROC为0.77(95%CI 0.76-0.77)。区分度随年龄增长显著下降:18-44岁AUROC 0.85(0.83-0.87)vs 75岁及以上0.72(0.70-0.73),ΔAUROC -0.14(95%CI -0.16至-0.11),老年患者被系统性低估。非英语使用者AUROC显著降低(ΔAUROC -0.04),但 documented 种族/民族组间无差异。人口学信息缺失患者死亡率显著高于总体7.2%(种族/民族缺失14.1%,语言缺失23.1%)。作者认为应将公平性评估常规纳入临床预测工具的验证。

要点

  • 总体AUROC 0.77(95%CI 0.76-0.77),SOFA-2对ICU死亡率区分度良好。
  • 年龄≥75岁AUROC 0.72(0.70-0.73)显著低于18-44岁0.85(0.83-0.87),ΔAUROC -0.14(95%CI -0.16至-0.11),老年患者风险被系统性低估。
  • 非英语使用者区分度显著降低(ΔAUROC -0.04), documented 种族/民族组间无显著差异。
  • 人口学信息缺失者死亡率显著高于总体7.2%:种族/民族缺失14.1%,语言缺失23.1%。
  • 作者认为应将公平性评估作为传统验证的补充常规开展。

适用人群与场景

  • 成人患者(≥18岁),至少一次ICU入住;分析每位患者首次合格住院的首次ICU入住。
  • 数据来源:美国东北部单中心学术医疗中心(Beth Israel Deaconess Medical Center, Boston, MA)MIMIC-IV数据库(版本3.1),2008-2022年,为SOFA-2开发队列之外的外部数据集。

诊断标准与关键阈值

  • SOFA-2评分:基于ICU入住第一个24小时内六个器官系统最差值计算首日SOFA-2评分。
  • 主要结局:ICU死亡率。

研究设计与关键结果

  • 研究设计:回顾性队列研究,外部验证;共纳入64,015例ICU患者,平均年龄64.6岁(标准差17.1),男性56.1%,白人66.1%。
  • 总体区分度:AUROC 0.77(95%CI 0.76-0.77)。
  • 年龄亚组:18-44岁AUROC 0.85(0.83-0.87)vs 75岁及以上0.72(0.70-0.73),ΔAUROC -0.14(95%CI -0.16至-0.11),老年患者存在系统性低估。
  • 语言亚组:非英语使用者AUROC显著降低(ΔAUROC -0.04)。
  • 种族/民族亚组: documented 种族/民族组间AUROC无显著差异。
  • 缺失数据:总体死亡率7.2%;种族/民族缺失者死亡率14.1%,语言缺失者死亡率23.1%,均显著高于总体。
  • 校准度:采用截距和斜率评估。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(外部验证)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • SOFA-2总体区分度良好,但用于老年(≥75岁)患者时可能低估死亡风险,临床决策需结合其他指标。
  • 非英语使用者中区分度下降,解读评分时应考虑语言因素。
  • 人口学信息缺失提示死亡高风险(种族/民族缺失14.1%,语言缺失23.1%),应关注数据完整性。
  • 作者认为应将公平性评估作为临床预测工具验证的常规补充。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the discrimination and calibration of the Sequential Organ Failure Assessment (SOFA)-2 score for ICU mortality across demographic subgroups defined by age, sex, race and ethnicity, primary language, and insurance status.

DESIGN: Retrospective cohort study.

SETTING: Single academic medical center in the northeastern United States (Beth Israel Deaconess Medical Center, Boston, MA), using the Medical Information Mart for Intensive Care-IV database (version 3.1), 2008-2022, a dataset external to the SOFA-2 development cohort.

PATIENTS: Adult patients (≥ 18 yr) with at least one ICU admission. The first ICU admission of the first qualifying hospitalization per patient was analyzed.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: First-day SOFA-2 scores were calculated from the worst values recorded during the first 24 hours of ICU admission across six organ systems, with ICU mortality as the primary outcome. Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC) and calibration using intercept and slope, with subgroup differences in AUROC estimated by bootstrap resampling. Among 64,015 ICU patients (mean [sd] age, 64.6 [17.1] yr; 56.1% male; 66.1% White), overall AUROC was 0.77 (95% CI, 0.76-0.77). Discrimination declined significantly with age: AUROC, 0.85 (0.83-0.87) for ages 18-44 years vs. 0.72 (0.70-0.73) for ages 75 or older (ΔAUROC, -0.14 [95% CI, -0.16 to -0.11]), with systematic underprediction in older patients. Discrimination was significantly decreased among non-English speakers (ΔAUROC, -0.04) but did not differ across documented racial/ethnic groups. Patients with missing demographic information had markedly higher mortality than the overall cohort rate of 7.2% (14.1% for missing race/ethnicity; 23.1% for missing language).

CONCLUSIONS: SOFA-2 demonstrated good overall performance but with clinically meaningful variation across subgroups, particularly with age and language. Patients with missing demographic data experienced markedly higher mortality. These findings argue for routine equity evaluation as a complement to traditional validation of clinical prediction tools.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ellen J, Hao S, Gao CA, et al. Evaluation of Sequential Organ Failure Assessment-2 Performance Across Demographic Subgroups: An External Validation Using MIMIC-IV. Crit Care Med. 2026. PMID: 43012622. doi:10.1097/CCM.0000000000007419

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。